Antimicrobial therapy in pneumococcal meningitis: an epidemiological assessment from Turkey

International Journal of Infectious Diseases

Volumn 10, Issue 3, 2006, Pages 262-263

  Erdem, Hakan ^a   Pahsa, Alaaddin ^a   Oncu, Serkan ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GATIFLOXACIN; GEMIFLOXACIN; GREPAFLOXACIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIMICROBIAL THERAPY; BACTERIAL MENINGITIS; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; LETTER; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; TURKEY (REPUBLIC); ANTIBIOTIC RESISTANCE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MENINGITIS, PNEUMOCOCCAL; TURKEY;

EID: 33745298310     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2005.03.009     Document Type: Letter

References (13)

1. Schuchat A.R.K., Robinson K., Wenger J.D., Harrison L.H., Farley M., Reingold A.L., et al. Bacterial meningitis in the United States in 1995. Active surveillance team. N Engl J Med 337 (1997) 970-976
2. Erdem H., and Pahsa A. The antibiotic resistance in pathogenic Streptococcus pneumoniae isolates in Turkey. J Chemother 17 (2005) 25-30
3. Sener B., and Gunalp A. Trends in antimicrobial resistance of Streptococcus pneumoniae in children in a Turkish hospital. J Antimicrob Chemother 42 (1998) 381-384
4. Gonullu N., and Berkiten R. Antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Istanbul. Int J Antimicrob Agents 16 (2000) 77-78
5. Kucukbasmaci O., Gonullu N., Aktas Z., Gurol D., and Berkiten R. In vitro activity of telithromycin compared with macrolides and fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. Int J Antimicrob Agents 22 (2003) 497-501
6. Zarakolu P., Soyletir G., Gur D., and Unal S. Antimicrobial resistance patterns of respiratory pathogens: a local report from Turkey. Clin Microbiol Infect 9 (2003) 1257-1258
7. Pinar A., Koseoglu O., Yenisehirli G., and Sener B. Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in a university hospital, Ankara, Turkey. Clin Microbiol Infect 10 (2004) 718-723
8. Friedland I.R., Paris M., Ehrett S., Hickey S., Olsen K., and McCracken Jr. G.H. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 37 (1993) 1630-1636
9. www.uptodate.com. Infectious diseases/CNS Infections/Principles of treatment and adjunctive therapies in bacterial meningitis (Uploaded April 2004).
10. Oncu S., Punar M., and Eraksoy H. Comparative activities of beta-lactam antibiotics and quinolones for invasive Streptococcus pneumoniae isolates. Chemotherapy 50 (2004) 98-100
11. Flatz L., Cottagnoud M., Kuhn F., Entenza J., Stucki A., and Cottagnoud P. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci. J Antimicrob Chemother 53 (2004) 305-310
12. Kuhn F., Cottagnoud M., Acosta F., Flatz L., Entenza J., and Cottagnoud P. Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro. Antimicrob Agents Chemother 47 (2003) 2487-2491
13. Cottagnoud P., Cottagnoud M., Acosta F., Flatz L., Kuhn F., Stucki A., et al. Meropenem prevents levofloxacin-induced resistance in penicillin-resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis. Eur J Clin Microbiol Infect Dis 22 (2003) 656-662